ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Lower levels of HMW adiponectin, which has potent anti-inflammatory and insulin-sensitizing effects, contribute significantly to metabolic dysfunction and liver inflammation in patients with NAFLD.